艾迪药业(688488.SH)：拟使用部分闲置募集资金不超过1亿元暂时补充流动资金

Core Viewpoint - Aidi Pharmaceutical (688488.SH) has announced the approval of a proposal to temporarily use part of its idle raised funds to supplement working capital, aiming to improve fund utilization efficiency and reduce financial costs [1] Group 1 - The company plans to use no more than 100 million yuan of idle raised funds for working capital, ensuring that it does not affect the progress of investment projects [1] - The funds will only be used for production and operations related to the company's main business [1] - The usage period for these funds will not exceed 12 months from the date of board approval [1]